FDA Licenses New Hepatitis B Vaccine Despite Big Safety Concerns
In February 2018, the Advisory Committee on Immunizations Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) approved the recommendation for a new hepatitis B vaccine, Heplisav-B (HepB-CpG) targeting for adults over the age of 18.1 Heplisav-B is manufactured by Dynavax Technologies Corp. and the new vaccine is given in a two-dose series versus the three […]
Defective DTaP Vaccines in China Due to “Uneven Ratio of Liquid”?
China’s top drug regulator, the China Food and Drug Administration (CFDA), announced on July 31, 2018 that a temporary equipment malfunction was to blame for the production of 400,520 faulty DTaP (diphtheria, tetanus, acellular pertussis) vaccines by Chinese pharmaceutical company Wuhan Institute of Biological Products Co. Ltd. of Wuhan (Hubei province), China.1 According to the China News […]